Approval · Notice of Compliance 32442 · 2024
MACROSYN: Notice of Compliance 32442
Issued January 3, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 32442
- Date
- January 3, 2024
- Company
- Bimeda-MTC Animal Health Inc.Cambridge, Ontario, Canada
- Product type
- Veterinary
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Canadian reference product
- DRAXXIN (Zoetis Canada Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MACROSYN | 02544229 | Marketed |
Medicinal ingredients
- TULATHROMYCIN 100 MG per ML